- Exchange: OTC US
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Affymax Inc+ Add to Watchlist
AFFY:US0.1200 USD 0.0070 5.51%
As of 13:34:23 ET on 12/22/2014.
Company Profile for Affymax Inc (AFFY)
Affymax Inc. is a clinical-stage biopharmaceutical company. The Company develops peptide-based drugs for the treatment of serious and life-threatening conditions such as kidney disease and cancer.
Key Executives for Affymax Inc (AFFY)
|Jonathan M CouchmanPresident/CEO||Mark G ThompsonChief Financial Officer|